Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-055732

Chief Executive Officer sold 100,000 shares at an average $58.21 ($5,821,032)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2020-10-23 Sale −87,728 $58.16 $5,102,260 2,517,509 D: show line 1 in the form
Anzalone Christopher Richard Chief Executive Officer 2020-10-23 Sale −12,272 $58.57 $718,771 2,505,237 D: show line 2 in the form
Open-market sales · 100,000 sh · avg $58.21 · $5,821,032
Loading xslF345X03/doc4.xml…